Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-036712
Filing Date
2022-12-28
Accepted
2022-12-28 20:38:13
Documents
2
Period of Report
2022-12-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3022
2 ex24.htm EX-24 8985
  Complete submission text file 0001493152-22-036712.txt   13244
Mailing Address
Business Address
GOLDSTEIN DOV A MD (Reporting) CIK: 0001120478 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-41583 | Film No.: 221496127

Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Issuer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations